Lidocaine Spray for Acute Postsurgical Pain Control After Posterior Pharyngeal Flap Surgery
This study evaluated the use of lidocaine spray for acute postsurgical pain control after posterior pharyngeal flap surgery. Fifty patients aged 4 to 14 years who were scheduled to undergo elective posterior pharyngeal flap surgery were randomized to receive 2.4% lidocaine spray (Group L) or an iden...
Saved in:
Published in | The Laryngoscope Vol. 134; no. 5; p. 2438 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2024
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | This study evaluated the use of lidocaine spray for acute postsurgical pain control after posterior pharyngeal flap surgery.
Fifty patients aged 4 to 14 years who were scheduled to undergo elective posterior pharyngeal flap surgery were randomized to receive 2.4% lidocaine spray (Group L) or an identical volume of placebo spray (Group C) on the surgical field at the end of the surgery. The primary outcome was the maximum postoperative pain score in the postanesthesia care unit.
The maximum pain score in Group L was significantly lower than that in Group C (p = 0.001). The incidence of moderate-to-severe pain in the postanesthesia care unit was significantly lower in Group L than that in Group C (p < 0.001). In the postanesthesia care unit, more patients in Group C were prescribed rescue analgesics (p < 0.001). The time to the first rescue analgesic was also significantly shorter in Group L (p < 0.001). The incidence and maximum score of emergence agitation were lower in Group L than in Group C. Compared with Group C, Group L showed earlier postoperative fluid intake (p = 0.001). Moreover, the score for parental satisfaction with pain control was higher in Group L than in Group C (p < 0.001).
Our findings indicated that the use of 2.4% lidocaine aerosol spray on the surgical site at the end of the surgery could produce good analgesia for acute postoperative pain, reduce the incidence and severity of EA, and shorten the time to restore fluid intake.
2 Laryngoscope, 134:2438-2443, 2024. |
---|---|
ISSN: | 1531-4995 |
DOI: | 10.1002/lary.31182 |